Bot Detector
IJPC Seal
Download FREE Sample Issue or Article
LEARN MORE
Subscribe Today
A subscription to IJPC includes a print copy delivered by postal mail and on-line access to electronic PDF copies of your subscribed issues.

How to Develop and Maintain a Hazardous Drug List

Author(s):  Dillon L Rad

Issue:  May/Jun 2019 - Volume 23, Number 3
View All Articles in Issue

Page(s):  182-186

How to Develop and Maintain a Hazardous Drug List Page 1
How to Develop and Maintain a Hazardous Drug List Page 2
How to Develop and Maintain a Hazardous Drug List Page 3
How to Develop and Maintain a Hazardous Drug List Page 4
How to Develop and Maintain a Hazardous Drug List Page 5

Download in electronic PDF format for $65

Abstract:  United States Pharmacopeia Chapter <800>, concerned with the handling of hazardous drugs in healthcare settings, requires that any entity handling such drugs maintain a hazardous drug list. While this list must include any drug found on the latest NIOSH List of Antineoplastic and Other Hazardous Drugs in Healthcare Settings, entities are expected to include other drugs and substances of concern. This article provides guidance on the creation and maintenance of such a list.

Related Keywords: L. Rad Dillon, RPh, MA, ASQ CMQ/OE, ASQ CQA, ACHC.PCAB CAC, CAC, AQ SSGB, United States Pharmacopeia Chapter <800> Hazardous Drugs - Handling in Healthcare Settings, Hazard Communication Standard, Occupational Safety and Health Agency, OSHA, National Institute for Occupational Safety and Health, NIOSH, List of Antineoplastic and Other Hazardous Drugs, workplace safety, worker exposure, carcinogenicity, teratogenicity, reproductive toxicity, low dose organ toxicity, genotoxicity, Globally Harmonised System of Classification and Labelling of Chemicals, safety data sheets

Related Categories: LEGAL, SUPPORT, UNITED STATES PHARMACOPEIA CONVENTIONS, ADVERSE DRUG EVENTS, HAZARDOUS DRUGS

Printer-Friendly Version



Related Articles from IJPC
Title/Author
(Click for Abstract / Details / Purchase)
Issue/​Page
View/Buy
How to Develop and Maintain a Hazardous Drug List
Dillon L Rad
May/Jun 2019
Pg. 182-186

Quality Control: Personal Protective Equipment for Use When Handling Hazardous Drugs
Dillon L R
Jan/Feb 2020
Pg. 30-36

Safety Standards in Pharmaceutical Compounding, Part 2: A Closer Look at Agency Information, Oversight, and Assistance
Greeson Nicole MH
, Mixon William, Allan W Chris
Sep/Oct 2020
Pg. 371-379

Performing a United States Pharmacopeia Chapter <800> Compliant Assessment of Risk
Cabaleiro Joe
Jan/Feb 2020
Pg. 21-27

PreScription: Permissible Exposure Limits and United States Pharmacopeia Chapter <800>
Allen Loyd V Jr
Sep/Oct 2021
Pg. 356

Why Become Pharmacy Compounding Accreditation Board Accredited?
Dillon L Rad
Nov/Dec 2016
Pg. 469-474

PreScription: United States Pharmacopeia Chapter <800> Comments and Alternatives
Allen Loyd V Jr
May/Jun 2017
Pg. 180

Safety Standards in Pharmaceutical Compounding, Part 3: Fire Safety
Allen W Chris
, Greeson Nicole MH, Mixon William
Nov/Dec 2020
Pg. 451-458

Safety Standards in Pharmaceutical Compounding, Part 1: The Occupational Safety and Health Administration
Greeson Nicole MH
, Mixon William, Allan W Chris
Jul/Aug 2020
Pg. 270-276

Standarized Compounding: The Importance of Doing it the Same Way Every Time
Dillon L Rad
Mar/Apr 2015
Pg. 109-112

Particle Measuring Systems - USP <797> Environmental Monitoring Solutions